Pharmaceutical / Drug Definition :
May reduce platelet production by decreasing megakaryocytic hypermaturation, thereby decreasing platelet count and inhibiting platelet aggregation (at higher doses)
FDA Label Requirements and Exceptions
Anagrelide Hydrochloride
FDA Import Information
Anagrelide Hydrochloride
FDA Detentions
Anagrelide Hydrochloride (Anagrelide Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Anagrelide Hydrochloride (Anagrelide Hydrochloride Suppliers)
- Processors Anagrelide Hydrochloride
- Repackers Anagrelide Hydrochloride
- Relabelers Anagrelide Hydrochloride
- Exporters Anagrelide Hydrochloride
- Importers Anagrelide Hydrochloride
For more information about Anagrelide Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
